Polarean Imaging PLC (AIM:POLX, OTC:PLLWF) is teaming up with SimonMed Imaging, one of America’s largest outpatient medical imaging providers.
It will see the AIM-quoted firm’s Xenon MRI platform delivered across the SimonMed network – starting with a site in Scottsdale, Arizona, later this year.
The partnership plans to enhance diagnostic capabilities for patients with pulmonary diseases such as asthma, chronic obstructive pulmonary disease (COPD), and unexplained dyspnea, Polarean highlighted in a statement.
"SimonMed's dedication to making imaging technologies widely accessible mirrors Polarean's vision of optimising lung health and illuminating hidden disease, making SimonMed an ideal collaboration partner,” Polarean chief executive Christopher von Jako said.
“Together, we aim to bring a much-needed imaging tool to clinicians, enabling them to see lung function with unprecedented clarity and precision to help them manage their patients' disease.
“We look forward to establishing a strong program in Scottsdale to serve as a model for potential expansion to several additional SimonMed's sites."
Dr John Simon, SimonMed founder and chief executive, added: “Our mission is to bring the newest diagnostic imaging technologies to the community in a way that is both accessible and affordable.
“Polarean's groundbreaking work with Xenon MRI aligns perfectly with our mantra, 'See Tomorrow Today'.
“This technology provides an unparalleled ability to visualise lung function, offering critical insights for patients with respiratory conditions such as asthma, COPD, and unexplained dyspnea.”
SimonMed operates over 170 facilities across eleven states in the United States.